Joy Chen

Joy Chen, Ph.D., is a strategic global leader currently serving as the Portfolio Strategy & Optimization Director at GSK, where they develop and implement business-focused portfolio strategies for medicines and vaccines across the GCI region. They have previously held leadership roles at several organizations, including Reckitt Benckiser Pharmaceuticals and Syneos Health, overseeing regulatory affairs and clinical development in various therapeutic areas such as oncology and infectious diseases. Joy’s extensive experience includes navigating regulatory processes and guiding product commercialization across multiple regions, including APAC, the USA, and Europe. They hold a Ph.D. in Pharmacology from Washington State University and a Master of Science in Neuropharmacology from the University of Illinois at Urbana-Champaign.